Key facts
- This page summarizes Oxford Science Enterprises plc's Form 4 filing for PepGen Inc. (PEPG).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 01 Oct 2025, 13:07.
Oxford Science Enterprises plc - 30 Sep 2025 Form 4 Insider Report for PepGen Inc. (PEPG)
- Reporting relationship
- Former 10% Owner
- Issuer ticker
- PEPG
- Reported as of
- 30 Sep 2025
- Net transaction value
- +$640,000
- SEC form
- 4
- Accepted by SEC
- 01 Oct 2025, 13:07:57 UTC
- Prior SEC filing
- 09 Apr 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jim Wilkinson
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Oxford Science Enterprises plc filed Form 4 for PepGen Inc. (PEPG) on 01 Oct 2025.
Change
- Previous filing in this sequence was filed on 09 Apr 2024.
- Current net transaction value: +$640,000.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001856079
Primary reporting owner
Oxford Science Enterprises plc
- Relationship
- Former 10% Owner
- Address
- 46 WOODSTOCK ROAD, OXFORD, UNITED KINGDOM
- Signature
- /s/ Jim Wilkinson
- Signature date
- 01 Oct 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PEPG
transaction
Common Stock
Purchase
- Transaction value
- $640,000
- Shares
- +200,000
- Change %
- +4.2%
- Price
- $3.20
- Shares after
- 4,955,388
- Date
- 30 Sep 2025
- Ownership
- Direct
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Oxford Science Enterprises plc is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
SEC remarks
On September 30, 2025, Oxford Science Enterprises plc purchased 200,000 shares of Common Stock at a price of $3.20 per share from the underwriters in the Issuer's public offering (the "2025 Public Offering"), bringing the total number of shares of Common Stock beneficially owned by Oxford Science Enterprises plc to 4,955,388. On September 24, 2025, the Issuer disclosed in its prospectus supplement, dated September 24, 2025, filed with the SEC on September 25, 2025, that it had 68,737,224 shares of Common Stock outstanding as of September 26, 2025. Accordingly, Oxford Science Enterprises plc is no longer deemed to beneficially own more than 10% of the Issuer's Common Stock. Oxford Science Enterprises plc is no longer subject to Section 16 of the Exchange Act with respect to the Issuer's Common Stock, and therefore will no longer report any such transactions on Form 4 or Form 5.